ProAssurance (NYSE:PRA) Upgraded at StockNews.com

StockNews.com upgraded shares of ProAssurance (NYSE:PRA) from a hold rating to a buy rating in a report published on Tuesday morning.

A number of other brokerages have also weighed in on PRA. Piper Sandler lowered ProAssurance from an “overweight” rating to a “neutral” rating and set a $18.00 price target on the stock. in a research note on Monday, November 11th. Truist Financial upped their price objective on shares of ProAssurance from $14.00 to $18.00 and gave the company a “hold” rating in a research note on Tuesday, November 12th.

ProAssurance Trading Down 0.1 %

ProAssurance stock opened at $16.74 on Tuesday. The stock has a market cap of $856.35 million, a PE ratio of 20.17 and a beta of 0.27. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.35. The stock has a 50-day moving average price of $15.96 and a 200 day moving average price of $14.00. ProAssurance has a 52 week low of $10.76 and a 52 week high of $17.79.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of PRA. Point72 Hong Kong Ltd acquired a new stake in shares of ProAssurance in the second quarter worth $28,000. nVerses Capital LLC acquired a new position in shares of ProAssurance during the third quarter worth about $44,000. Innealta Capital LLC purchased a new stake in shares of ProAssurance in the second quarter worth about $69,000. Point72 Asia Singapore Pte. Ltd. grew its stake in shares of ProAssurance by 94.3% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 8,347 shares of the insurance provider’s stock valued at $126,000 after buying an additional 4,052 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC acquired a new position in ProAssurance during the 2nd quarter worth approximately $166,000. Hedge funds and other institutional investors own 85.58% of the company’s stock.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.